XBI

SPDR S&P BIOTECH ETF · PSE

  • Category Health Care
  • Expense Ratio 0.35%
  • Listing Date Feb 06, 2006
  • Volume 9,330,730.0
  • Market Cap (AUM) $6,490.38M

Performance

-3.57%

1W

-9.58%

1M

-3.96%

3M

+2.54%

6M

+5.64%

YTD

+19.64%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Novavax, Inc.NVAX2.80%
  • Insmed IncorporatedINSM2.61%
  • Twist Bioscience Corp.TWST1.49%
  • Moderna, Inc.MRNA1.43%
  • United Therapeutics CorporationUTHR1.39%
  • Dyne Therapeutics IncDYN1.38%
  • Natera, Inc.NTRA1.34%
  • Halozyme Therapeutics, Inc.HALO1.33%
  • Geron CorporationGERN1.31%
  • Revolution Medicines, Inc.RVMD1.30%

Technical Analysis of XBI 2024-12-12

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score of 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.